Brainsway (BWAY) Net Income towards Common Stockholders (2018 - 2026)
Brainsway's (BWAY) quarterly Net Income towards Common Stockholders came in at $2.3 million in Q1 2026, up 106.87% YoY from $1.1 million in Q1 2025, and down 31.13% on a QoQ basis from $3.3 million in Q4 2025.
Brainsway (BWAY) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has 9 years of Net Income towards Common Stockholders data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 106.87% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (up 135.08% YoY) and the FY2025 annual result came in at $7.6 million, up 159.33% from the prior year.
- Net Income towards Common Stockholders declined to $2.3 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $3.3 million in Q4 2025 to a low of -$5.0 million in Q3 2022.
- A 5-year average of -$253529.4 and a median of $127000.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 187.08% — and 2024, when it soared 1118.9%.
- Tracing BWAY's Net Income towards Common Stockholders over 5 years: stood at -$3.9 million in 2022, then surged by 103.28% to $127000.0 in 2023, then soared by 1118.9% to $1.5 million in 2024, then soared by 114.79% to $3.3 million in 2025, then sank by 31.13% to $2.3 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $2.3 million (Q1 2026), $3.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Brainsway | 567.23 Mn | 504.06 Mn | 12.77 Mn | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.29 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 662,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Sep 30, 2023 | -230,000.00 |
| Jun 30, 2023 | -1.66 Mn |
| Mar 31, 2023 | -2.43 Mn |
| Dec 31, 2022 | -3.87 Mn |
| Sep 30, 2022 | -5.04 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -1.99 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -1.94 Mn |